First Hawaiian Bank Bioventus Inc. Transaction History

First Hawaiian Bank

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 12, 2022	BUY	$12.37 - $16.77 $20,657 - $28,005	1,670 Added 5.17%	33,980 $492,000
Q3 2021 Oct 12, 2021	BUY	$13.7 - $17.25 $100,489 - $126,528	7,335 Added 29.37%	32,310 $458,000
Q2 2021 Jul 08, 2021	BUY	$13.75 - $18.8 $343,406 - $469,530	24,975 New	24,975 $440,000

143

45.8M

179K

124K

Ticker BVS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 61,664,200
Market Cap $647M
Description
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...

Get notified when there are updates to the investment portfolio of First Hawaiian Bank, based on Form 13F filings with the SEC.

Stay updated on First Hawaiian Bank with notifications on news.